abstract |
FIELD: medicine. n SUBSTANCE: what is described are drug conjugates which contain an incretin therapeutic or diagnostic agent who is fused or conjugated with an antigen-binding antibody fragment which binds serum albumin. n EFFECT: conjugates have prolonged in vivo half-life in comparison with an unconjugated or unfused therapeutic or diagnostic agent. n 27 cl, 19 dwg, 8 tbl, 18 ex |